AT299233B - Verfahren zur Herstellung von neuen Carbaminsäureestern - Google Patents

Verfahren zur Herstellung von neuen Carbaminsäureestern

Info

Publication number
AT299233B
AT299233B AT1069670A AT1069670A AT299233B AT 299233 B AT299233 B AT 299233B AT 1069670 A AT1069670 A AT 1069670A AT 1069670 A AT1069670 A AT 1069670A AT 299233 B AT299233 B AT 299233B
Authority
AT
Austria
Prior art keywords
preparation
acid esters
carbamic acid
new carbamic
new
Prior art date
Application number
AT1069670A
Other languages
English (en)
Inventor
Peder Bernhard Berntsson
Arne Elof Braendstroem
Ulf Krister Junggren
Bo Robert Lamm
Lars Samuel Palmer
Bengt Erik Wilander
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Application granted granted Critical
Publication of AT299233B publication Critical patent/AT299233B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
AT1069670A 1969-12-09 1970-11-27 Verfahren zur Herstellung von neuen Carbaminsäureestern AT299233B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6012969 1969-12-09

Publications (1)

Publication Number Publication Date
AT299233B true AT299233B (de) 1972-06-12

Family

ID=10485066

Family Applications (3)

Application Number Title Priority Date Filing Date
AT384571A AT299234B (de) 1969-12-09 1970-11-27 Verfahren zur Herstellung von neuen Carbaminsäureestern
AT384671A AT303953B (de) 1969-12-09 1970-11-27 Verfahren zur Herstellung eines Mittels zur Hemmung der Chlorwasserstoffsekretion des Magens
AT1069670A AT299233B (de) 1969-12-09 1970-11-27 Verfahren zur Herstellung von neuen Carbaminsäureestern

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT384571A AT299234B (de) 1969-12-09 1970-11-27 Verfahren zur Herstellung von neuen Carbaminsäureestern
AT384671A AT303953B (de) 1969-12-09 1970-11-27 Verfahren zur Herstellung eines Mittels zur Hemmung der Chlorwasserstoffsekretion des Magens

Country Status (7)

Country Link
AT (3) AT299234B (de)
AU (1) AU2222570A (de)
BE (1) BE758427A (de)
DE (2) DE2062374A1 (de)
FR (1) FR2081335A1 (de)
NL (1) NL7017727A (de)
ZA (1) ZA707100B (de)

Also Published As

Publication number Publication date
AT303953B (de) 1972-12-27
AT299234B (de) 1972-06-12
DE2062374A1 (de) 1971-06-24
BE758427A (fr) 1971-04-16
AU2222570A (en) 1972-05-18
ZA707100B (en) 1971-07-28
FR2081335A1 (en) 1971-12-03
NL7017727A (de) 1971-06-11
DE2054124A1 (de) 1971-06-24

Similar Documents

Publication Publication Date Title
CH509247A (de) Verfahren zur Herstellung von neuen Cycloalkenonestern
CH459977A (de) Verfahren zur Herstellung von neuen Thiocarbaminsäureestern
CH507956A (de) Verfahren zur Herstellung von neuen Diisocyanaten
AT317165B (de) Verfahren zur Herstellung von γ-Alkoxyacetessigsäureestern
AT311997B (de) Verfahren zur Herstellung von neuen 1-Imidazolyl-methanphosphonsäureestern
AT321904B (de) Verfahren zur herstellung von neuen aminothiophencarbonsäureestern
AT293350B (de) Verfahren zur Herstellung von α-Oxycarbonsäureestern
CH529139A (de) Verfahren zur Herstellung von Benzimidazol-2-carbaminsäureestern
AT310134B (de) Verfahren zur Herstellung von Perflouralkylalkan oder -cycloalkan-monocarbonsäureestern
CH524584A (de) Verfahren zur Herstellung von Thiocarbamidsäureestern
AT305242B (de) Verfahren zur Herstellung von neuen α-Aminoxycarbonsäreamiden
AT287683B (de) Verfahren zur Herstellung von neuen Kohlensäuremischestern
AT296337B (de) Verfahren zur Herstellung von neuen Amidothionophosphorsäurephenylestern
CH538514A (de) Verfahren zur Herstellung von 2-Chloräthyl-dithiophosphonsäureestern
AT297031B (de) Verfahren zur Herstellung von neuen 2,4-Dioxo-1,3-benzoxazino-thionophosphonsäureestern
AT303255B (de) Verfahren zur Herstellung von neuen Acylaminopenicillansäuren
AT289829B (de) Verfahren zur Herstellung von neuen N,N-Bis-halogenmethyl-carbaminsäureestern
AT311323B (de) Verfahren zur Herstellung von neuen Perflouralkylalka-bzw.-cycloalkanmonocarbonsäureestern
AT300773B (de) Verfahren zur Herstellung von neuen Estern der p-Biphenylylessigsäure
AT298434B (de) Verfahren zur Herstellung von neuen 3-Acetoxy-2-methylen-propionsäurealkylestern
CH538479A (de) Verfahren zur Herstellung von neuen Estern von Hydroxy-isochinuclidin
CH537896A (de) Verfahren zur Herstellung von Perfluoralkancarbonsäureestern
CH524576A (de) Verfahren zur Herstellung von Dichlormethylencarbaminsäureestern
AT315148B (de) Verfahren zur Herstellung von neuen substituierten 3-Phenyl-2-halogen-thiopropionsäureestern
AT297026B (de) Verfahren zur Herstellung von neuen O-Alkyl-O-phenyl-thiono-thiolphosphonsäureestern

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee